Inventaire - your friends and communities are your best library

Whole Tumor Antigen Vaccines: Where Are We?

author

George Coukos

1950 -

published in: Vaccines

date of publication: 2015-04-23

language: English

Cites articles 126

Date

Title

Authors

2014-12-08

Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy

Aileen Li
2014-09-16

A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer

Amaraporn Wongrakpanich, Aliasger Salem
2013-02-20

Combining radiotherapy and cancer immunotherapy: a paradigm shift

Sandra Demaria
2013-02

Tumor stroma as targets for cancer therapy
2013-11-19

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

Charles G. Drake
2013-09-20

Antitumor immune responses induced by ionizing irradiation and further immune stimulation

Rainer Fietkau, Benjamin Frey
2013-07-09

A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside

Rosemarie Mick, Brian Czerniecki, Bruce L. Levine
2013-07-02

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Gustav Gaudernack, Einar Osland Vik-Mo, Iver Arne Langmoen, Eirik Helseth, Gunnar Kvalheim
2013-05-05

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Yong-Chen Lu, Colin Gross, Jamie K Teer, Eric Tycksen, Yardena Samuels, Steven Rosenberg
2012-03

Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer

John Nemunaitis
2012-12-21

The cancer antigenome

Bianca Heemskerk
2012-07-13

Deciphering the message broadcast by tumor-infiltrating dendritic cells

Ruurd Torensma, Jurjen Tel
2012-06-15

Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice

Marcus Groettrup
2012-02-08

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

James P. Allison, Mark J. Smyth, Matthew D Vesely, Elaine Mardis, Lloyd J. Old
2012-01-11

Exploiting the mutanome for tumor vaccination

Sebastian Boegel, Uğur Şahin, Sebastian Kreiter, Mustafa Diken, Christoph Huber, Özlem Türeci, Martin Löwer, Abderraouf Selmi, Michael Koslowski, Jan Diekmann, Claudia Paret, Cedrik M Britten, Niels van de Roemer
2012-02-06

Dissection of T-cell antigen specificity in human melanoma

Charlotte Albaek, Niels Junker, Marco Donia, Inge Marie Svane, Per thor Straten, Sine Reker Hadrup
2011-06-29

Integrated genomic analyses of ovarian carcinoma

Cancer Genome Atlas Research Network, William Schierding
2011-08-15

Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment

Ian S Hagemann, George Coukos
2011-06-01

Complexity of dendritic cell subsets and their function in the host immune system
2011-04-01

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines

George Coukos
2011-03-01

Exploring the genomes of cancer cells: progress and promise
2011-01-01

Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin

George Coukos
2011-01-01

Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics

Uğur Şahin, Özlem Türeci, Sebastian Kreiter, Mustafa Diken, Britta Vallazza
2010-06-01

RNA vaccines in cancer treatment
2010-11-02

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity

Uğur Şahin, Sebastian Kreiter, Mustafa Diken, Christoph Huber, Özlem Türeci, Abderraouf Selmi, Michael Koslowski, Cedrik M Britten
2010-10-25

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

Irit Avivi
2010-03-30

Whole tumor antigen vaccines
2010-01-28

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma

Jay A Berzofsky
2009-12-03

Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.

Cécile Viboud, Mark A. Miller, Stefano Bertozzi, Gerardo Chowell
2009-11-01

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

Gemma Kenter, Cornelis J. M. Melief
2009-09-01

Targets of protective tumor immunity
2009-06-25

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

Article - wd:Q26783866

Welcome to Inventaire

the library of your friends and communities

learn more